1. Introduction {#sec1}
===============

Catheter based ablation is a common treatment option in patients who either failed or declined medical therapy for atrial fibrillation (AF). With the incidence and prevalence of atrial fibrillation increasing worldwide, the frequency of catheter based ablations also continues to rise. Ablation of AF most commonly involves creating circumferential lesions around the pulmonary vein ostia or antra with or without the placement of additional ablation lesions within the left atrium \[[@bib3]\]. The left atrium is anterior to the esophagus \[[@bib3],[@bib4]\]. The close proximity of the esophagus to the left atrium makes it susceptible to potential injury during catheter based ablation of AF \[[@bib7]\].

While the possible complication of atrioesophageal fistula is rare post catheter ablation of AF, it is, none-the-less a severe, life -threatening complication that is one of the most feared \[[@bib1],[@bib3],[@bib6]\]. It is estimated to occur in 1 of 500--1000 cases \[[@bib6]\]. The mortality rate associated with AEF has been reported to surpass 60%--80% \[[@bib5],[@bib10]\].

We have reviewed the clinical characteristics, discuss diagnostic modalities and determine the most definitive treatment options available, in order to recognize and promptly treat AEF, given its fatal outcome \[[@bib1]\].

2. Methods {#sec2}
==========

2.1. Search strategy {#sec2.1}
--------------------

The purpose of this study was to collate cases of AEF post ablation for AF that were identified from published reports in the literature. PubMed is a searchable online database and service of the US National Library of Medicine that provides access to medical journal articles. A systemic search of the database PubMed from inception to June 2017 was performed. The search terms included "atrioesophageal fistula" or "atrio-esophageal fistula" or "esophagoatrial fistula" or "esophago-atrial fistula." These terms were searched as free text in the title or the abstract \[[@bib1]\]. In addition, Google Scholar, another searchable online database, was systemically searched with the same terms as above. Lastly, we reviewed reference lists of bibliographies of the listed articles.

2.2. Selection criteria {#sec2.2}
-----------------------

Case reports selected reported: (1) the primary diagnosis as AF for ablation procedure; (2) clinical presentation; (3) diagnostic imaging; (4) management and (5) outcome \[[@bib1]\].

2.3. Statistical analysis {#sec2.3}
-------------------------

For this systemic review of case reports, we used the Preferred Reporting Items for Systemic Reviews and Meta-Analyses (PRISMA) statement protocol. Chi-squared analyses were used to determine differences in percentages between groups. Statistical significance was set at 0.05 \[[@bib1]\].

3. Results {#sec3}
==========

3.1. Demographics and clinical presentation {#sec3.1}
-------------------------------------------

Sixty-five cases of AEF post atrial fibrillation ablation were reviewed and compiled into a table ([Table 1](#tbl1){ref-type="table"}). The mean age was 55 years old. 73.8% (48/65) of the identified cases occurred in males and 26.2% (17/65) occurred in females (p \< 0.001) ([Fig. 1](#fig1){ref-type="fig"}). Of the 65 cases, 13 (20%) underwent surgical RFA and 52 (80%) underwent percutaneous RFA. Mortality resulted in 53.8% of those who underwent surgical RFA and in 55.8% of those who underwent percutaneous RFA (p \< 0.888) ([Fig. 2](#fig2){ref-type="fig"}). Given these results, there is no clinical significance in mortality between those who underwent surgical versus percutaneous radiofrequency ablation. The range interval from procedure to onset of symptoms was 1--60 days ([Table 1](#tbl1){ref-type="table"}) \[[@bib1],[@bib3]\]. Fever occurred most commonly in 52 of the 65 cases, followed by neurological symptoms such as hemiparesis, stroke/TIA, motor and language impairment which occurred in 44 cases. Patients also presented with hematemesis (n = 21), chest pain (n = 19), altered mental status (n = 18), seizures (n = 12), dysphagia (n = 6), loss of consciousness (n = 5), nausea/vomiting (n = 5), abdominal pain (n = 3), cough (n = 3), dyspnea (n = 2), headache (n = 2), melena (n = 1), and odynophagia (n = 1) ([Fig. 3](#fig3){ref-type="fig"}).Fig. 1The total number of males compared to females found to have atrioesophageal fistula post atrial fibrillation ablation. 73.8% (48/65) of the identified cases occurred in males and 26.2% (17/65) occurred in females (p \< 0.001).Fig. 1Fig. 2Comparison of the number of patients with AEF who initially underwent surgical radiofrequency (RFA) versus percutaneous RFA for treatment of atrial fibrillation. Of the 65 cases, 13 (20%) underwent surgical RFA and 52 (80%) underwent percutaneous RFA. Mortality resulted in 53.8% (7/13) of those who underwent surgical RFA and in 55.8% (29/52) of those who underwent percutaneous RFA (p \< 0.888). Thus, there is no difference in mortality between patients who underwent surgical RFA versus percutaneous RFA.Fig. 2Fig. 3The frequency of symptoms in patients with AEF post atrial fibrillation at the initial time of presentation. Symptoms will likely occur in a triad of fever, neurological deficits (such as hemiparesis) and/or hematemesis, all three of which make up the most frequent clinical presentations identified.Fig. 3Table 1Case reports included.Table 1Author\# of CasesGenderAge (years)ProcedurePost proce-dure DayClinical presentationImaginingFindingsDiagnostic ProcedureTreatmentOutcomePappone et al. \[[@bib4]\]1Male59CPVA2Chest pain, fever, weakness, rigors, grand mal seizuresTTE/TEE\
CT of the headunremarkableAutopsyNonsurgical, AntibioticsDeathMohanty et al. \[[@bib8]\]9Male46RFCA\
8 = endocardial catheter based radiofrequency\
1 = hybrid endo- epicardial left atrial ablation\
- - - - - - - - - - - - -\
7 = intraluminal temperature monitoring with esophageal probe\
- - - - - - - - - - - - - - -\
4 = general anesthesia\
5 = conscious sedation21Fever, leukocytosis, stroke/TIA, Bilateral arm weaknessChest CT w/contrast TTEAEFChest CT w/contrastEsophageal Stent\
IV antibiotics\
AnticoagulationDeathMale6128Fever, leukocytosis, stroke/TIA, hemiparesis, seizureChest CT w/contrast TTEAEFChest CT w/contrastEsophageal Stent\
IV antibiotics\
AnticoagulationDeathMale4535Fever, stroke TIA, leukocytosis, grand mal seizures, focal cortical signsChest CT w/contrast TTEAEFChest CT w/contrastEsophageal Stent\
IV antibiotics\
AnticoagulationDeathMale5828Chest pain, stroke/TIA, leukocytosis, hemiparesis, confusionChest CT w/contrast TTEAEFChest CT w/contrastEsophageal Stent\
IV antibiotics\
AnticoagulationDeathFemale6242Stroke/TIA systemic embolism, chest pain, GI hemorrhage, leukocytosis, decreased reflexes, paresisChest CT w/contrast TTEAEFChest CT w/contrastEsophageal Stent\
IV antibiotics\
AnticoagulationDeathMale5128Fever, chest pain, sepsis, stroke/TIA. Leukocytosis, AMS, hemiparesisChest CT w/contrast TTEAEFChest CT w/contrastSurgery\
IV antibiotics\
AnticoagulationSurvivedMale5914Fever, rigor, chest pain, sepsis, GI bleed, stroke/TIA, sudden blindness weak legChest CT w/contrast TTEAEFChest CT w/contrastSurgery\
IV antibiotics\
AnticoagulationSurvivedMale4221Fever, rigor, chest pain, sepsis, stroke/TIA, sudden blindness weak legChest CT w/contrast TTEAEFChest CT w/contrastSurgery\
IV antibiotics\
AnticoagulationSurvivedMale5628Fever, chest pain, dysphagia, confusion, leukocytosis, postprandial TIA, multiple petechiae, weak armChest CT w/contrast TTEAEFChest CT w/contrastSurgery\
IV antibiotics\
AnticoagulationSurvivedPappone et al. \[[@bib9]\]1Male36Percutaneous: CPVA3Fever, Pleuritic chest pain, seizuresCT of the headBilateral ischemiaCT of chestSurgicalSurvivedPappone et al. \[[@bib9]\]1Male21Percutaneous: CPVA1Fever, Grand mal seizureCT of the headUnremarkableTEENon-surgicalDeathAryana et al. \[[@bib11]\]1Female55MAZE21Seizures, left hemiparesis, severe chest painHead CTCerebral pneumo-cephalusChest CTANon-surgicalDeathVassileva \[[@bib12]\]1Female72Percutaneous radiofrequency isolation of the pulmonary veins14Shortness of breath, nonproductive cough, palpitations, elevated WBC, seizureHead CT\
Chest CTAir in the left atriumChest CTSurgerySurvivedSonmez et al. \[[@bib13]\]1Female58Surgical: LRFA -- melo technique22Fever, shivers, numbness right armTTELA thrombusEGDThrombectomy, pericardial suturesDeathDoll et al. \[[@bib14]\]1Male42Surgical: IRAAF10Fever, postprandial TIATTENormalExploratory thoracotomySurgicalSurvivedDoll et al. \[[@bib14]\]1Female62Surgical: IRAAF6Hematemesis,EGDNAPathologyNoneDeathDoll et al. \[[@bib14]\]1Male59Surgical: IRAAF12Fever, neurological symptomsCT of the chestContrast and free air in the mediastinumExploratory thoracotomySurgicalSurvivedDoll et al. \[[@bib14]\]1Male36Surgical: IRAAF11Chest painCT of the chestEsophageal perforationExploratory thoracotomySurgicalSurvivedScanavacca et al. \[[@bib15]\]1Male72Percutaneous: RFA22Seizures, HematemesisNANAEGDNoneDeathZirlik and Nordt \[[@bib16]\]1Male66Surgical: MVR and MAZE procedure14CollapseCT of the headMultiple intracerebral air emboli and infarctionEGDNon-surgicalDeathBunch et al. \[[@bib17]\]1Male48Percutaneous: RFA14Fever, chest pain, dysphagiaCT of the chest3 mm esophageal perforation at the level of the atriumEGDNon-surgicalSurvivedSchley et al. \[[@bib18]\]1Male37Percutaneous: RFA25Fever, Grand mal seizure, status epilepticusCT of the headIschemic lesionsCT of chestSurgicalSurvivedCummings et al. \[[@bib19]\]9Male = 4\
Female = 5NAPercutaneous: PRFA12.3 (10--16)Sepsis (9), neurological symptoms (8), angina (2), GI bleed (3), occult bleed (5)CT of the headIntravascular air (2)CT of chest (3/4); autopsy(6/9)Surgical = 3Death = 9Dagres et al. \[[@bib20]\]5Male = 4\
Female = 151 (35--76)Surgical: RFA (n = 4); Percutaneous: RFA (n = 1)8--28Fever (3) chest pain (2), hemiparesis (3), grand mal seizure (1), aphasia (1)NAFree air in mediastinum (3), pericardium (1), left atrium (1)CT of chestSurgery = 3\
- - - - - - - - -\
Attempted surgery = 2Survived = 3\
- - - - - - -\
Death 2Preis et al. \[[@bib21]\]1Male56Percutaneous: PVI with RFA38Malaise, chills, bilateral arm weaknessTEENo vegetationsCT of chestSurgicalSurvivedMalamis et al. \[[@bib22]\]1Male59Percutaneous: RFA35Fever, altered mental status, petechiaeCT of the headNegativeCT of chestSurgicalDeathD\'Avila et al. \[[@bib23]\]1Male56Percutaneous: RFA28Epigastric pain, dysphagia, tactile fever, focal weakness, anomia, acalculia, agraphiaMRI of the brainMultiple subacute embolic eventsCT of chestSurgicalSurvivedBorchert et al. \[[@bib24]\]1Male59Percutaneous: PVI with HIFU ablation catheter10Chest discomfort and atypical atrial flutter; VF arrestMRI of the brainCerebral and Cerebellar ischemic lesionsCT of chestSurgicalDeathOuchikhe et al. \[[@bib25]\]1Male58Percutaneous: RFA21Fever, confusion, meningitisCT of the headBilateral hyperdense lesions (frontal, occipital parietal and temporal)TTENonsurgicalDeathHazell et al. \[[@bib26]\]1Male72Percutaneous: PVI roofline mitral isthmus line CFAE16Weakness, loss of concsiousness, chest painCT of the headRight parietal subcortical matter ischemic changesCT of chestNonsurgicalDeathVijayaraman et al. \[[@bib27]\]1Male45Percutaneous: RFA with 3D reconstruction10Chest pain, low grade fever, hypotensionCT of the chestFluid and air in pericardium and air in right superior mediastinumThoraco-tomySurgicalSurvivedBaker et al. \[[@bib28]\]1Female67Surgical: RFA20Substernal chest pain, nausea, vomiting, confusion, fever, seizures, hematemesisMRI of the brainMultiple acute emboliEGDNonsurgicalDeathCazavet et al. \[[@bib29]\]1Male35Percutaneous: RFA38Fever, chest pain, vomiting, left hemiplegia and seizuresCT of the headInitially negativeCT of chestSurgicalSurvivedGilcrease et al. \[[@bib30]\]1Male61Percutaneous: RFA10Dysphagia, substernal chest pain, feverCT of the chestUlcer at anterior portion esophagus adjacent to PVCT of chest (after 2 monhts)SurgicalDeathKhandhar et al. \[[@bib31]\]1Male46Percutaneous: RFA27Fever, pericarditis, followed by hemiparesisCT of the chestNormalCT of chestSurgicalSurvivedSiegel et al. \[[@bib32]\]1Male41Percutaneous: RFA30Fever, rigors near syncope; followed by right sided hemiparesisMRI of the brainMultifactorial infractsCT of chestSurgicalSurvivedGrubina et al. \[[@bib33]\]1Male72Percutaneous: RFA9Pleuritic chest painCT of the chest PAD \# 15Pneumo-pericardiumEGDSurgicalSurvivedSt Julien et al. \[[@bib34]\]1Male59Percutaneous: transeptal LA ablation with ThermoCool catheter42Chest pain, diaphoresis, headache, fever, altered mental statusTTENo vegetationsCT of chestSurgicalSurvivedZellerhoff et al. \[[@bib35]\]1Male63Percutaneous: RFA with 3D mapping14Muscle weakness, generalized fatigue followed by fever and left sided hemiparesisCT of the headSeveral large intracerebral lesions suspicious for air embolismCT of chestNonsurgicalDeathPurerfellner et al. \[[@bib36]\]1Male49Percutaneous: RFA29Fever, chills, nausea, emesis, altered mental status, athetotic movements, skin changes, hematemesisEGDUnable to localize source of bleedingEGDNonsurgicalDeathStockigt et al. \[[@bib37]\]1Male78Percutaneous: cryoballoon PV isolation28Fever, shivers, cough for 10 days, followed by neurological symptomsCT of the chest and abdomenNegativeCardiac CTNonsurgicalSurvivedTancevski et al. \[[@bib38]\]1Male45Percutaneous: transcatheter ablation42Fever, weakness, sensory loss of right limbsCT of the chest and abdomenCT of chest: AEF; CT of abdomen: multiple renal and splenic infarctionsCT surgerySurgicalSurvivedHaggery et al. \[[@bib39]\]1Male27Percutaneous: PV RFA22Fever, chills, hypotension, hematemesisCT of the chestPneumo-mediastinum adjacent to LACT surgerySurgicalSurvivedKanth and Fang \[[@bib40]\]1Female69Percutaneous: RFA60Sepsis, ischemic stroke, melenaCT of the chestAEFEGDNonsurgicalDeathBen-David et al. \[[@bib41]\]1Female73Percutaneous: RFA9Pneumo-mediastinumUGI series4 mm esophageal perforation at 6 cm from GEJEGDSurgicalSurvivedHartman et al. \[[@bib42]\]1Male62Percutaneous: RFA30Odynophagia, fever, chills, rigors, syncopeCardiac CathNegativeCT of chestSurgicalSurvivedZini et al. \[[@bib43]\]1Male44Percutaneous: RFA--Altered mental status, stuporCT of the headMultifocal air emboliEGDAntibiotics, antithrombotics, fistula repairDeathRivera et al. \[[@bib44]\]1Female50Percutaneous: RFA28Minor hematemesisCT of the chestAEF and plural effusionsEGDSurgicalSurvivedTan Coffey \[[@bib45]\]1Female67Surgical: MVR and MAZE procedure20Nausea, fever, numbness of the left foot; unresponsiveCT of the headCT of the head: air embolism RSFACT of chestNonsurgicalDeathShim et al. \[[@bib46]\]1Male46Percutaneous: RFA2Fever, chills, cough, headache; confusion, generalized tonic-clonic seizuresTTE/TEENo thrombusCT of chestSurgicalSurvivedNeven et al. \[[@bib47]\]1Male69Percutaneous: HIFU31Fever, hematemesis, seizures, phrenic nerve palsyCT of the headCerebral embolismAutopsyNonsurgicalDeathDixit et al. \[[@bib48]\]1FemaleNAPercutaneous: PV isolation14Fever, nausea, hematemesisEGDPossible Mallory-Weiss tearCT of headNonsurgicalDeath[^1]

3.2. Diagnostic modalities, treatment and outcome {#sec3.2}
-------------------------------------------------

Among the diagnostic modalities employed were CT of the chest (n = 37), transthoracic echocardiogram (n = 21), and CT of the head (n = 18)([Fig. 4](#fig4){ref-type="fig"}). Air embolism was most commonly identified in 17 patients, followed by pneumomediastinum identified in 12 patients ([Table 1](#tbl1){ref-type="table"}).Fig. 4Frequency of diagnostic modalities used to confirm AEF.(CCTA, computed cardiac tomographic angiograph; CT abd/pelvis, CT of the abdomen and pelvis with contrast; CT chest, CT of the chest with intravenous contrast; CT head, CT of the head without contrast; MRI brain, MRI of the brain; TEE, transesophageal echocardiogram; TTE, transthoracic echocardiogram).Fig. 4

Of the total 65 cases reviewed, 36 resulted in deaths, whether surgically or non-surgically treated. Thus, the total mortality rate of all cases reviewed was 55 .4%, making atrioesophageal fistula a rare, but grave outcome post atrial fibrillation ablation.

Patients who underwent surgical correction with esophageal repair for treatment were more likely to survive, in comparison to patients who were treated with non-surgical interventions, such as antibiotic therapy, anticoagulation therapy or esophageal stenting. Mortality rates were significantly reduced in those who underwent surgical intervention at 20.6% (7/34) versus a mortality rate of 93.5% (29/31) in patients who were not treated surgically (p \< 0.001) ([Fig. 5](#fig5){ref-type="fig"}).Fig. 5Comparison of patients with AEF post AF ablation who underwent surgical correction with esophageal repair versus those who underwent non -surgical interventions, such as esophageal stenting, antibiotic therapy or no intervention at all. Overall, patients who underwent surgical correction had a higher survival rate at 79.4% (27/34) compared to those who were treated non-surgically (p \< 0.001).Fig. 5

4. Discussion {#sec4}
=============

Atrioesophageal fistula, an uncommon but adverse event of atrial fibrillation catheter based ablation, is associated with a high fatality rate. The mortality rate associated with surgical RFA was 53.8% (7 deaths in a total of 13 patients who underwent surgical RFA) versus 55.8% with percutaneous RFA (29 deaths in a total of 52 patients who underwent percutaneous RFA) (p \< 0.001). Thus, there is no difference in mortality between surgical RFA and percutaneous RFA.

Patients may present with non-specific symptoms, ranging from 1 to 60 days after the ablation ([Fig. 6](#fig6){ref-type="fig"}) \[[@bib1],[@bib3]\]. Common symptoms may include a triad of fever, neurological deficits (such as hemiparesis) and/or hematemesis \[[@bib1]\]. Other symptoms may include chest discomfort, altered mental status, seizures, abdominal pain, nausea, vomiting, dysphagia, odynophaga, melena, and dyspnea ([Fig. 3](#fig3){ref-type="fig"}). Given the high mortality rate, it is essential to hold a high index of clinical suspicion in patients who recently underwent ablation for AF and present with such non-specific symptoms \[[@bib1],[@bib3],[@bib7]\].Fig. 6Patients may present with non-specific symptoms, ranging from less than 1 week to 9 weeks after the ablation.Fig. 6

The most common diagnostic modality for identifying AEF following AF ablation includes CT of the chest, TTE and CT of the head. Other methods of imaging used included esophogram, MRI of the brain, TEE, CT of the abdomen or pelvis, and Cardiac CTA ([Fig. 4](#fig4){ref-type="fig"}). Concern has been raised regarding the performance of esophagoscopy in the setting of potential AEF, in which air insufflation into the esophagus could push air or esophageal contents into the left atrium.

The total mortality rate of cases reviewed, with surgical and nonsurgical interventions, was 55.4% (36 total deaths out of 65 total cases). 79.4% of patients with AEF post AF ablation survived after undergoing surgical correction with esophageal repair, compared to 6.5% of patients who were treated with non-surgical interventions. Overall, patients who underwent surgical repair were twelve times more likely to survive than those treated with stenting, antibiotic therapy or no intervention at all \[[@bib5]\]. With such a large survival advantage conferred by definitive surgical intervention, we advocate that definitive and prompt surgical intervention should be the standard of care for such a dreaded complication ([Fig. 5](#fig5){ref-type="fig"}).

5. Limitations {#sec5}
==============

This is a retrospective review of published cases of AEF, and it is likely that many cases of AEF have not been published and so not available to include in this review. It is not possible from these data to assess or compare the incidence of AEF with catheter or surgical ablation. Additionally, there may be important differences between patients who underwent surgical versus non-surgical treatment for AEF which might have impacted the mortality rates of these patients.

6. Conclusions {#sec6}
==============

Atrioesophageal fistula is an uncommon but adverse event of atrial fibrillation catheter based ablation associated with increased fatality. Patients who underwent surgical repair were twelve times more likely to survive than those treated with stenting, antibiotic therapy or no intervention. Based on the observation that patients are 12 times more likely to survive an AEF with surgery than without, the authors believe that prompt surgical correction of AEF should be considered as standard of care when dealing with this dreaded complication.

Peer review under responsibility of Indian Heart Rhythm Society.

[^1]: AEF, atrioesophageal fistula; AMS, altered mental status; CFAE, complex fractionated atrial electrograms; CPVA, circumferential pulmonary vein ablation; EGD, esophagoduodenoscopy; GEJ gastroesophageal junction; GI, gastrointestinal; HIFU, high-intensity focused ultrasound; IRAAF, intra-operative radiofrequency ablation of atrial fibrillation; IV, intravenous; LA, left atrium; LRFA, linear radiofrequency ablation; MVR, mitral valve replacement; NA, not available; PAD, post-ablation day; PV, pulmonary veins; PVI, pulmonary vein isolation; RFA, radiofrequency ablation; RFCA, radiofrequency catheter ablation; RSFA, right superior frontal area; TEE, transesophageal echocardiogram; TIA, transient ischemic attack; TTE, transthoracic echocardiogram; UGI, upper gastrointestinal; VF, ventricular fibrillation; WBC, white blood cells.
